NANOPARTICLE TUMOUR VACCINES
    1.
    发明公开
    NANOPARTICLE TUMOUR VACCINES 审中-公开
    纳米粒子肿瘤疫苗

    公开(公告)号:EP2753361A1

    公开(公告)日:2014-07-16

    申请号:EP12768753.1

    申请日:2012-09-07

    IPC分类号: A61K47/48 A61P35/00

    摘要: The present invention provides a vaccine for the prophylactic or therapeutic treatment of a tumour in a mammalian subject, as well as methods of using the vaccine, including in treatment of tumours and in generating a CTL response. The vaccine comprises a plurality of nanoparticles and a pharmaceutically acceptable carrier, salt or diluent. The nanoparticles comprise a core comprising a metal and/or a semiconductor atom; and a corona comprising a plurality of ligands covalently linked to the core, wherein at least a first ligand of said plurality comprises a carbohydrate moiety that iscovalently linked to the core via a first linker, and wherein at least a second ligand of said plurality comprises an epitopic peptide that is covalently linked to the core via a second linker, said second linker comprising a peptide portion and a non-peptide portion, wherein said peptide portion comprises the sequence X
    1 X
    2 Z
    1 , wherein: X
    1 is an amino acid selected from A and G; X
    2 is an amino acid selected from A and G; and Z
    1 is an amino acid selected from Y and F, and wherein said epitopic peptide forms at least a portion of or is derived from a Tumour-Associated Antigen (TAA).